AI assistant
Sending…
RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2017
Oct 10, 2017
30849_dirs_2017-10-10_6e8b2d0f-cf4a-4306-90c9-d24701c9be27.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2017-10-04
Reporting Person: SILVERSTEIN JONATHAN (Director)
More from RHYTHM PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2